Abstract:Idiopathic pulmonary fibrosis is a well-known age-related disease. However, much less recognized has been the aging associated pathogenesis of this disorder. As we and others previously showed that dysregulation of micro-RNAs (miRNAs) was an important mechanism involved in pulmonary fibrosis, the role of these molecules in this pathology in the aged population has not been investigated (Cushing L, Kuang PP, Qian J, Shao F, Wu J, Little F, Thannickal VJ, Cardoso WV, Lü J. Am J Respir Cell Mol Biol 45: 287-294, 2011; Liu G, Friggeri A, Yang Y, Milosevic J, Ding Q, Thannickal VJ, Kaminski N, Abraham E. J Exp Med 207: 1589-1597, 2010; Pandit KV, Corcoran D, Yousef H, Yarlagadda M, Tzouvelekis A, Gibson KF, Konishi K, Yousem SA, Singh M, Handley D, Richards T, Selman M, Watkins SC, Pardo A, Ben-Yehudah A, Bouros D, Eickelberg O, Ray P, Benos PV, Kaminski N. Am J Respir Crit Care Med 182: 220-229, 2010). In this study, by using a lung fibrosis model established in old mice, we found that ablation of miR-34a protected aged animals from developing experimental lung fibrosis. miR-34a was upregulated in lung epithelial cells, but not in lung fibroblasts of aged mice, and miR-34a expression was further increased in epithelial cells of the fibrotic lungs of these old animals. We found that miR-34a induced dysfunctions in alveolar epithelial cells (AECs), as evidenced by increased cellular senescence and apoptosis and mitochondrial aberrations. More importantly, these abnormalities were attenuated in AECs of the fibrotic lungs of aged miR-34a-/- mice. We found that miR-34a targeted Sirt1, a master anti-aging regulator, and two key cell cycle modulators, E2F3 and cyclin E2, in lung epithelial cells, and the repression of these targets was relieved in miR-34a-deficient AECs. In summary, our data suggest that elevated AEC miR-34a plays a critical role in the pathogenesis of pulmonary fibrosis in the aged population. Our study also indicates miR-34a to be a more precise miRNA target for treating this disease that overwhelmingly affects people of advanced age.

FGF receptors mediate cellular senescence in the cystic fibrosis airway epithelium

Prolonged WNT/ß-catenin signaling induces cellular senescence in aging and pulmonary fibrosis

Aged alveolar epithelium contributes to inflammaging and reduced stem cell function in the lung

Eotaxin-1/CCL11 promotes cellular senescence in human-derived fibroblasts through pro-oxidant and pro-inflammatory pathways

Molecular programs of fibrotic change in aging human lung

What the future holds: cystic fibrosis and aging

Cellular Senescence in Lung Fibrosis

A Troy Horse in Pulmonary Fibrosis

Regulation of Cellular Senescence Is Independent from Profibrotic Fibroblast-Deposited ECM

Aging increases senescence, calcium signaling, and extracellular matrix deposition in human airway smooth muscle

The profibrotic and senescence phenotype of old lung fibroblasts is reversed or ameliorated by genetic and pharmacological manipulation of Slc7a11 expression

The ageing of people living with cystic fibrosis: what to expect now?

The potential role of senescence in limiting fibrosis caused by aging

Curculigoside Attenuates Endoplasmic Reticulum Stress-Induced Epithelial Cell and Fibroblast Senescence by Regulating the SIRT1-P300 Signaling Pathway

A cGAS-dependent response links DNA damage and senescence in alveolar epithelial cells: a potential drug target in IPF

Modulating in vitro lung fibroblast activation via senolysis of senescent human alveolar epithelial cells

Cellular Senescence in the Lung: The Central Role of Senescent Epithelial Cells

miR-34a promotes fibrosis in aged lungs by inducing alveolarepithelial dysfunctions

Epithelial cell senescence induces pulmonary fibrosis through Nanog-mediated fibroblast activation

Molecular mapping of interstitial lung disease reveals a phenotypically distinct senescent basal epithelial cell population

FSTL1 promotes alveolar epithelial cell aging and worsens pulmonary fibrosis by affecting SENP1‐mediated DeSUMOylation